Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Investigator-blind Multi-center Prospective Study for the Efficacy and Safety of Silicon Gel (Dermatix) in the Prevention of Hypertrophic Scar in Subjects Undergoing Caesarean Section

NCT01004536 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01004536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01004536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Investigator-blind Multi-center Prospective Study for the Efficacy and Safety of Silicon Gel (Dermatix) in the Prevention of Hypertrophic Scar in Subjects Undergoing Caesarean Section
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2010
Completion date
February 28, 2011
Enrollment
47 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cicatrix